Impact of lung cancer screening results on smoking cessation
- PMID: 24872540
- PMCID: PMC4081623
- DOI: 10.1093/jnci/dju084
Impact of lung cancer screening results on smoking cessation
Abstract
Background: Lung cancer screening programs may provide opportunities to reduce smoking rates among participants. This study evaluates the impact of lung cancer screening results on smoking cessation.
Methods: Data from Lung Screening Study participants in the National Lung Screening Trial (NLST; 2002-2009) were used to prepare multivariable longitudinal regression models predicting annual smoking cessation in those who were current smokers at study entry (n = 15489, excluding those developing lung cancer in follow-up). The associations of lung cancer screening results on smoking cessation over the trial period were analyzed. All hypothesis testing used two sided P values.
Results: In adjusted analyses, smoking cessation was strongly associated with the amount of abnormality observed in the previous year's screening (P < .0001). Compared with those with a normal screen, individuals were less likely to be smokers if their previous year's screen had a major abnormality that was not suspicious for lung cancer (odds ratio [OR] = 0.811; 95% confidence interval [CI] = 0.722 to 0.912; P < .001), was suspicious for lung cancer but stable from previous screens (OR = 0.785; 95% CI = 0.706 to 0.872; P < .001), or was suspicious for lung cancer and was new or changed from the previous screen (OR = 0.663; 95% CI = 0.607 to 0.724; P < .001). Differences in smoking prevalence were present up to 5 years after the last screen.
Conclusions: Smoking cessation is statistically significantly associated with screen-detected abnormality. Integration of effective smoking cessation programs within screening programs should lead to further reduction in smoking-related morbidity and mortality.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Figures
Comment in
-
Lung cancer screening and smoking cessation: a teachable moment?J Natl Cancer Inst. 2014 May 28;106(6):dju122. doi: 10.1093/jnci/dju122. Print 2014 Jun. J Natl Cancer Inst. 2014. PMID: 24872542 Free PMC article. No abstract available.
References
-
- Moyer VA. Screening for lung cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2013. [published ahead of print December 31, 2013]. - PubMed
-
- Jacobson FL, Austin JH, Field JK, et al. Development of the American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of the American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. J Thorac Cardiovasc Surg. 2012;144(1):25–32 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01-CN-25524/CN/NCI NIH HHS/United States
- N01-CN-25513/CN/NCI NIH HHS/United States
- N01-CN-75022/CN/NCI NIH HHS/United States
- N01-CN-25514/CN/NCI NIH HHS/United States
- N01-CN-25512/CN/NCI NIH HHS/United States
- N01 CN025511/CA/NCI NIH HHS/United States
- N01-CN-25515/CN/NCI NIH HHS/United States
- N01 CN075022/CA/NCI NIH HHS/United States
- N02 CN063300/CA/NCI NIH HHS/United States
- N01 CN025518/CA/NCI NIH HHS/United States
- N01-CN-25516/CN/NCI NIH HHS/United States
- N01 CN025515/CA/NCI NIH HHS/United States
- N01-CN-25522/CN/NCI NIH HHS/United States
- N01-CN-25511/CN/NCI NIH HHS/United States
- N01 CN025512/CA/NCI NIH HHS/United States
- N01 CN025522/CA/NCI NIH HHS/United States
- N01 CN025513/CA/NCI NIH HHS/United States
- N01 CN025524/CA/NCI NIH HHS/United States
- N01 CN025476/CA/NCI NIH HHS/United States
- N02-CN-63300/CN/NCI NIH HHS/United States
- N01 CN025516/CA/NCI NIH HHS/United States
- N01-CN-25518/CN/NCI NIH HHS/United States
- N01 CN025514/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
